Medical Weight Loss for Lancaster, California Residents

Lancaster, California residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Lancaster through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Two GLP-1 options, shipped to Lancaster: compounded semaglutide shares its active ingredient with Wegovy and Ozempic, and tirzepatide with Mounjaro and Zepbound. These are not FDA-approved and not brand-identical; Dr. Sharma helps California patients choose. Doctor review just $119 (medication separate).

Why Lancaster Residents Choose New Hope Weight Loss

At New Hope Weight Loss, every case in Lancaster is overseen by a named physician, Dr. Anjmun Sharma, MD. You are not handed off to a rotating panel of strangers or a faceless intake bot. Dr. Sharma reviews your history, signs off on your plan, and stays accountable for it. That single point of medical responsibility is rare in telehealth, and it is the reason so many people across California trust us to guide a serious decision about their health.

Lancaster residents do not need a local clinic to start. Our physician-led program is delivered by secure video from Costa Mesa, California, with flat nationwide pricing and compounded medication mailed in cold-pack packaging to your Lancaster address.

For anyone in Lancaster, California, the distance to Costa Mesa simply does not matter, because Dr. Anjmun Sharma manages your entire program by video and message rather than in person. We care for patients throughout the Boulevard, downtown, and the Antelope Valley of Los Angeles County. Compounded semaglutide and tirzepatide are not FDA-approved and not brand-identical, and Dr. Sharma will walk you through what that means for you in plain terms.

By handling visits through telehealth, we serve every neighborhood in Lancaster, from the Boulevard, downtown, and the Antelope Valley of Los Angeles County, without asking anyone to travel. Please note that our compounded semaglutide and tirzepatide are not FDA-approved and are not brand-identical, and results vary from person to person. California is our home state and our physical clinic sits in Costa Mesa, but we care for patients across the rest of the state by secure telehealth.

GLP-1 Weight Loss Programs Available

Begin your reset: semaglutide, from $166/mo

The 90-Day Metabolic Reset gives Lancaster patients a structured three-month plan with semaglutide, the active ingredient shared with Wegovy and Ozempic. Choose $166 a month or $499 for the whole 90 days. In trials of the branded drug, the average was around 15 to 17 percent body-weight loss. Compounded semaglutide is not FDA-approved and not brand-identical, and results vary.

Go further: tirzepatide, from $233/mo

Tirzepatide hits both GLP-1 and GIP receptors for a dual effect. Qualifying doses in branded-drug trials reached up to 22.5 percent loss, which is not what most patients should expect. It carries the same active ingredient as Mounjaro and Zepbound.

Each plan begins with a $119 physician review. Medication is billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Lancaster

Getting started in Lancaster is simple, and you never have to leave home. Begin with a short intake quiz about your health history, weight goals, and any medications you take. Dr. Anjmun Sharma reviews your answers and meets you by secure video, usually within 48 hours, to talk through whether compounded semaglutide or tirzepatide is a reasonable fit. If she prescribes, a state-licensed 503(a) pharmacy ships your medication straight to your Lancaster address in cold-pack packaging that keeps it stable in transit. From there, your follow-up visits happen by video too, so dose checks and questions stay easy no matter where in you live.

Frequently Asked Questions, Lancaster

Does New Hope Weight Loss have a presence in Lancaster?

Our presence in Lancaster is through telehealth rather than a storefront. The clinic itself is in Costa Mesa, California, our sole physical location. We serve Lancaster, California patients online, and Dr. Anjmun Sharma confirms your eligibility for compounded semaglutide or tirzepatide during a private video consultation.

Could a Lancaster patient complete care without leaving home?

Yes, staying home is the norm. Everything for Lancaster patients runs over telehealth, including the initial consult, dose adjustments, and check-ins. After approval, your medication travels to Lancaster in insulated cold-pack shipping that protects it from temperature swings during delivery.

How are Lancaster patients charged?

There is a $119 fee for the physician review. Semaglutide starts at $166 monthly, with a 90-day option at $499, and tirzepatide at $233 monthly. The medication itself is a separate cost. We accept HSA, FSA, Klarna, and Affirm, and we add no distance surcharge for Lancaster.

What areas of Lancaster do you serve?

We serve patients from across Lancaster by telehealth, including the Boulevard, downtown, and the Antelope Valley of Los Angeles County.

Are there hidden fees for Lancaster patients?

No. Lancaster patients pay the same flat, stated pricing: a $119 physician visit, then compounded semaglutide from $166/month or tirzepatide from $233/month with medication billed separately. There is no membership lock-in and no distance surcharge.

Lancaster Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Lancaster, California by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.